Overview

Study to Compare the Safety and Pharmacokinetics of PK101 With Coadministration of the Two Separate Drugs

Status:
Completed
Trial end date:
2019-08-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and pharmacokinetics of PK101(fixed-dose combination of PK101-001 and PK101-002) with coadministration of the two separate drugs in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
PMG Pharm Co., Ltd